中文速读
本研究针对前列腺癌,通过体内转染siRNA-FBP1至DU145细胞并接种裸鼠,以及体外转染siRNA-FBP1或pcDNA3.1-Flag-FBP1至PC-3细胞,使用Entranster-in vivo试剂,发现FBP1基因沉默通过激活MAPK通路促进前列腺癌细胞EMT、侵袭和转移。
小鼠siRNA质粒DNADU145PC-3
The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway
Yan-Ping Zhang 1 , Kai-Long Liu 1 , Zhan Yang 1 , Bao-Sai Lu 1 , Jin-Chun Qi 1 , Zhen-Wei Han 1 , Yue-Wei Yin 1 , Ming Zhang 1 , De-Min Chen 1 , Xiao-Wei Wang 1 , Wei Li 1 , Hong Xin 2 Affiliations
- PMID: 31448674
- PMCID: PMC6739050
- DOI: 10.1080/15384101.2019.1648956
Free PMC article
Abstract
Prostate cancer (PCa) is a frequently occurring malignancy in males, and epithelial mesenchymal transition (EMT) plays a critical role in PCa metastasis. Thus, developing biomarkers inhibiting EMT may provide significance for treatment of PCa. Hence, the aim of the current study was to investigate the mechanism by which FBP1 gene silencing influences PCa cell EMT, invasion and metastasis by mediating the MAPK pathway. PCa cell lines exhibiting the highest FBP1 expression were selected and treated with plasmids of siRNA-FBP1 sequence 1 and 2, pcDNA3.1-Flag-FBP1 (over-expression plasmid of FBP1), U0126 (an inhibitor of the ERK signaling pathway) and PD98059 (an inhibitor of the MEK signaling pathway). Cell proliferation, migration and invasion were detected by MTT assay, wound healing assay and Transwell assay, respectively. The mRNA and protein expression of related factors of EMT and MAPK signaling were determined by RT-qPCR and western blot analysis, respectively. Xenograft tumor growth after inoculation of DU145 cells was regularly analyzed in the nude mice. The positive expression of EMT markers was determined by immunohistochemistry. DU-145 and PC-3 cells displaying the highest FBP1 expression were selected for further analysis. The PCa cells treated with siRNA-FBP1 exhibited increased proliferation, migration rate and invasion, in addition to facilitated xenograft tumor growth. Notably, siRNA-FBP1 was identified to accelerate PCa cell EMT by elevating the expression of Vimentin and N-cadherin while diminishing E-cadherin expression via activation of the MAPK signaling pathway. The aforementioned results were reversed in PCa cells treated by pcDNA3.1-Flag-FBP1. Evidence has been provided in this study that FBP1 gene silencing activates the MAPK pathway, which ultimately promotes cell EMT, invasion and metastasis in PCa.
Keywords: FBP1; MAPK signaling pathway; epithelial-mesenchymal transition; invasion; metastasis; prostate cancer.
小核酸转染试剂Entranster™-R4000 已有 223 篇已发表文献
同类研究
- Biomolecules. 2026 May 19;16(5):741.doi: 10.3390/biom16050741. Up-Regulation of the TRPM8 Channel Attenuates TRPC1-Media…
- FASEB J. 2026 May 15;40(9):e71855.doi: 10.1096/fj.202503895RR. High-Fat Diet Induces Inflammatory Injury in Mice Sertoli…
- Biochem Pharmacol. 2026 Jan 20:246:117723.doi: 10.1016/j.bcp.2026.117723. Small nucleolar RNA host gene 3 regulates seps…
- Autoimmunity. 2025 Dec;58(1):2576881.doi: 10.1080/08916934.2025.2576881. High glucose promotes O-GlcNAcylation of ACSL4…
- BMC Cancer. 2025 Oct 10;25(1):1553.doi: 10.1186/s12885-025-14854-x. PCBP1-AS1 facilitates liver metastasis in pancreatic…